CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C02604 | BRD-K00624509 | VU-0011562 | -- | -- | -- | Details |
| C02605 | BRD-K00627859 | tubastatin-a | HDAC6 | HDAC inhibitor | -- | Details |
| C02606 | BRD-K00628863 | BRD-K00628863 | -- | -- | -- | Details |
| C02607 | BRD-K00631971 | BRD-K00631971 | -- | -- | -- | Details |
| C02608 | BRD-K00636532 | BRD-K00636532 | -- | -- | -- | Details |
| C02609 | BRD-K00637033 | BRD-K00637033 | -- | -- | -- | Details |
| C02610 | BRD-K00640357 | BRD-K00640357 | -- | -- | -- | Details |
| C02611 | BRD-K00643888 | BRD-K00643888 | -- | -- | -- | Details |
| C02612 | BRD-K00645031 | BRD-K00645031 | -- | -- | -- | Details |
| C02613 | BRD-K00656370 | 6-aminochrysene | -- | -- | 6-AMINOCHRYSENE | Details |
| C02614 | BRD-K00662280 | CL-218872 | GABRA1 | GABA receptor agonist | -- | Details |
| C02615 | BRD-K00663064 | BRD-K00663064 | -- | -- | -- | Details |
| C02616 | BRD-K00663349 | BRD-K00663349 | -- | -- | -- | Details |
| C02617 | BRD-K00664012 | BRD-K00664012 | -- | -- | -- | Details |
| C02618 | BRD-K00667983 | BRD-K00667983 | -- | -- | -- | Details |
| C02619 | BRD-K00668050 | BRD-K00668050 | -- | -- | -- | Details |
| C02620 | BRD-K00671069 | BRD-K00671069 | -- | -- | -- | Details |
| C02621 | BRD-K00673382 | famotidine | HRH2 | Histamine receptor antagonist | -- | Details |
| C02622 | BRD-K00674894 | orteronel | CYP17A1 | Cytochrome P450 inhibitor; Androgen receptor antagonist; Androgen biosynthesis inhibitor | -- | Details |
| C02623 | BRD-K00675675 | CL-82198 | MMP13 | Metalloproteinase inhibitor | -- | Details |
| C02624 | BRD-K00676343 | BRD-K00676343 | -- | -- | -- | Details |
| C02625 | BRD-K00685640 | BRD-K00685640 | -- | -- | -- | Details |
| C02626 | BRD-K00689442 | BRD-K00689442 | -- | -- | -- | Details |
| C02627 | BRD-K00692337 | BRD-K00692337 | -- | -- | -- | Details |
| C02628 | BRD-K00695053 | BRD-K00695053 | -- | -- | -- | Details |
| C02629 | BRD-K00697836 | BRD-K00697836 | -- | -- | -- | Details |
| C02630 | BRD-K00698280 | BRD-K00698280 | -- | -- | -- | Details |
| C02631 | BRD-K00715257 | BRD-K00715257 | -- | -- | -- | Details |
| C02632 | BRD-K00717406 | BRD-K00717406 | -- | -- | -- | Details |
| C02633 | BRD-K00740489 | BRD-K00740489 | -- | -- | -- | Details |
| C02634 | BRD-K00744507 | BRD-K00744507 | -- | -- | -- | Details |
| C02635 | BRD-K00747273 | BRD-K00747273 | -- | -- | -- | Details |
| C02636 | BRD-K00754679 | BRD-K00754679 | -- | -- | -- | Details |
| C02637 | BRD-K00761520 | BRD-K00761520 | -- | -- | -- | Details |
| C02638 | BRD-K00765103 | BRD-K00765103 | -- | -- | -- | Details |
| C02639 | BRD-K00765599 | BRD-K00765599 | -- | -- | -- | Details |
| C02640 | BRD-K00766422 | sparfosic-acid | CAD | Aspartate carbamoyltransferase inhibitor | -- | Details |
| C02641 | BRD-K00766524 | BRD-K00766524 | -- | -- | -- | Details |
| C02642 | BRD-K00767817 | BRD-K00767817 | -- | -- | -- | Details |
| C02643 | BRD-K00773626 | BRD-K00773626 | -- | -- | -- | Details |
| C02644 | BRD-K00789767 | BRD-K00789767 | -- | -- | -- | Details |
| C02645 | BRD-K00793226 | BRD-K00793226 | -- | -- | -- | Details |
| C02646 | BRD-K00797068 | BRD-K00797068 | -- | -- | -- | Details |
| C02647 | BRD-K00799745 | BRD-K00799745 | -- | -- | -- | Details |
| C02648 | BRD-K00801367 | BRD-K00801367 | -- | -- | -- | Details |
| C02649 | BRD-K00801770 | BRD-K00801770 | -- | -- | -- | Details |
| C02650 | BRD-K00804254 | BRD-K00804254 | -- | -- | -- | Details |
| C02651 | BRD-K00808919 | BRD-K00808919 | -- | -- | -- | Details |
| C02652 | BRD-K00812396 | BRD-K00812396 | -- | -- | -- | Details |
| C02653 | BRD-K00816125 | BRD-K00816125 | -- | -- | -- | Details |
| C02654 | BRD-K00816165 | BRD-K00816165 | -- | -- | -- | Details |
| C02655 | BRD-K00816476 | BRD-K00816476 | -- | -- | -- | Details |
| C02656 | BRD-K00816633 | BRD-K00816633 | -- | -- | -- | Details |
| C02657 | BRD-K00818202 | BRD-K00818202 | -- | -- | -- | Details |
| C02658 | BRD-K00819343 | BRD-K00819343 | -- | -- | -- | Details |
| C02659 | BRD-K00824317 | BRD-K00824317 | -- | -- | fludroxycortide | Details |
| C02660 | BRD-K00835182 | dexamethasone | NR3C1 | Glucocorticoid receptor agonist | -- | Details |
| C02661 | BRD-K00835201 | BRD-K00835201 | -- | -- | -- | Details |
| C02662 | BRD-K00837228 | BRD-K00837228 | -- | -- | -- | Details |
| C02663 | BRD-K00842536 | BRD-K00842536 | -- | -- | -- | Details |
| C02664 | BRD-K00845702 | BRD-K00845702 | -- | -- | -- | Details |
| C02665 | BRD-K00846846 | BRD-K00846846 | -- | -- | -- | Details |
| C02666 | BRD-K00846914 | BRD-K00846914 | -- | -- | -- | Details |
| C02667 | BRD-K00848147 | BRD-K00848147 | -- | -- | -- | Details |
| C02668 | BRD-K00853241 | BRD-K00853241 | -- | -- | -- | Details |
| C02669 | BRD-K00853706 | BRD-K00853706 | -- | -- | -- | Details |
| C02670 | BRD-K00859168 | BRD-K00859168 | -- | -- | -- | Details |
| C02671 | BRD-K00859238 | BRD-K00859238 | -- | -- | -- | Details |
| C02672 | BRD-K00863274 | BRD-K00863274 | -- | -- | -- | Details |
| C02673 | BRD-K00863322 | BRD-K00863322 | -- | -- | -- | Details |
| C02674 | BRD-K00865615 | BRD-K00865615 | -- | -- | -- | Details |
| C02675 | BRD-K00867929 | BRD-K00867929 | -- | -- | -- | Details |
| C02676 | BRD-K00868395 | BRD-K00868395 | -- | -- | -- | Details |
| C02677 | BRD-K00877314 | BRD-K00877314 | -- | -- | -- | Details |
| C02678 | BRD-K00878439 | BRD-K00878439 | -- | -- | -- | Details |
| C02679 | BRD-K00882360 | BRD-K00882360 | -- | -- | -- | Details |
| C02680 | BRD-K00883748 | BRD-K00883748 | -- | -- | -- | Details |
| C02681 | BRD-K00885784 | canrenone | NR3C2 | Mineralocorticoid receptor antagonist | -- | Details |
| C02682 | BRD-K00889002 | BRD-K00889002 | -- | -- | -- | Details |
| C02683 | BRD-K00892322 | BRD-K00892322 | -- | -- | -- | Details |
| C02684 | BRD-K00900096 | BRD-K00900096 | -- | -- | -- | Details |
| C02685 | BRD-K00907050 | BRD-K00907050 | -- | -- | -- | Details |
| C02686 | BRD-K00909602 | BRD-K00909602 | -- | -- | -- | Details |
| C02687 | BRD-K00910650 | BRD-K00910650 | -- | -- | -- | Details |
| C02688 | BRD-K00911143 | brexpiprazole | DRD2; HTR1A; HTR2A | Dopamine receptor partial agonist | -- | Details |
| C02689 | BRD-K00913793 | BRD-K00913793 | -- | -- | -- | Details |
| C02690 | BRD-K00914921 | BRD-K00914921 | -- | -- | -- | Details |
| C02691 | BRD-K00918977 | BRD-K00918977 | -- | -- | -- | Details |
| C02692 | BRD-K00920341 | BRD-K00920341 | -- | -- | -- | Details |
| C02693 | BRD-K00925050 | BRD-K00925050 | -- | -- | -- | Details |
| C02694 | BRD-K00927991 | BRD-K00927991 | -- | -- | -- | Details |
| C02695 | BRD-K00930335 | BRD-K00930335 | -- | -- | -- | Details |
| C02696 | BRD-K00933790 | BRD-K00933790 | -- | -- | -- | Details |
| C02697 | BRD-K00935206 | BRD-K00935206 | -- | -- | -- | Details |
| C02698 | BRD-K00938507 | sulfamethoxypyridazine | -- | -- | -- | Details |
| C02699 | BRD-K00938872 | BRD-K00938872 | -- | -- | -- | Details |
| C02700 | BRD-K00944562 | BRD-K00944562 | -- | -- | -- | Details |
| C02701 | BRD-K00946569 | BRD-K00946569 | -- | -- | -- | Details |
| C02702 | BRD-K00950228 | BRD-K00950228 | -- | -- | -- | Details |
| C02703 | BRD-K00951345 | BRD-K00951345 | -- | -- | -- | Details |